Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Red deer hair cells offer a new way to study how hormones affect hair growth.

Hormones and genes affect hair growth and male baldness.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Hormonal factors may affect female hair loss, needing further research and treatment ideas.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Testosterone increases fluid secretion and aquaporin expression in the vas deferens, which is important for male fertility.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The oral contraceptive improved hair and skin quality in women.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Finasteride treats hair loss but may affect prostate cancer detection.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Hormones and stretching both needed for nipple area skin growth in mice.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.